The table below shows aTYR PHARMA INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$61.99M
-$69.12M
-$33.22M
-$41.89M
-$33.08M
-$15.30M
Capital expenditure
$77.00K
$65.00K
$4.21M
$1.64M
$192.00K
$202.00K
Investing cash flow
-$5.05M
$17.23M
-$20.13M
$47.24M
-$91.57M
$6.90M
Dividends paid
-
-
-
-
-
LIFE operating cash flow (10-K history)
aTYR PHARMA INC reported operating cash flow of -$61.99M for fiscal year 2025. That is up 10.3% from -$69.12M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$52.86M (FY 2016) to -$61.99M. Figures come from the company's audited annual reports as filed with the SEC.
